Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    DICE Therapeutics Inc.

    NASDAQ: DICE · Real-Time Price · USD
    47.55
    0.03 (0.06%)
    At close: Aug 08, 2023, 8:00 PM

    DICE Therapeutics Statistics

    Share Statistics

    DICE Therapeutics has 47.76M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 47.76M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 50,004

    FTD / Avg. Volume

    n/a
    		 2.85%

    Short Selling Information

    The latest short interest is 4.36M, so 9.13% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.36M

    Short % of Shares Out

    n/a
    		 9.13%

    Short % of Float

    n/a
    		 14.6%

    Short Ratio (days to cover)

    n/a
    		 5.2

    Valuation Ratios

    The PE ratio is -15.05 and the forward PE ratio is null. DICE Therapeutics's PEG ratio is 0.32.

    PE Ratio

    n/a
    		 -15.05

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -6.55

    P/FCF Ratio

    n/a
    		 -18.47

    PEG Ratio

    n/a
    		 0.32
    Financial Ratio History

    Enterprise Valuation

    DICE Therapeutics has an Enterprise Value (EV) of 781.19M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -9.41

    EV / EBIT

    n/a
    		 -12.14

    EV / FCF

    n/a
    		 -11.74

    Financial Position

    The company has a current ratio of 38.14, with a Debt / Equity ratio of -0.07.

    Current Ratio

    n/a
    		 38.14

    Quick Ratio

    n/a
    		 38.14

    Debt / Equity

    n/a
    		 -0.07

    Debt / EBITDA

    n/a
    		 -0.16

    Debt / FCF

    n/a
    		 -0.2

    Interest Coverage

    n/a
    		 -129.93

    Financial Efficiency

    Return on Equity is 43.53% and Return on Invested Capital is 49.26%.

    Return on Equity

    n/a
    		 43.53%

    Return on Assets

    n/a
    		 -13.75%

    Return on Invested Capital

    n/a
    		 49.26%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,150,197.18

    Employee Count

    n/a
    		 71

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.22M

    Effective Tax Rate

    n/a
    		 2.65%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so DICE Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 45.12

    200-Day Moving Average

    n/a
    		 34.83

    Relative Strength Index (RSI)

    n/a
    		 77.58

    Average Volume (20 Days)

    n/a
    		 1,753,229

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -88.22M

    Net Income

    n/a
    		 -81.66M

    EBITDA

    n/a
    		 -83.01M

    EBIT

    n/a
    		 -83.21M

    Earnings Per Share (EPS)

    n/a
    		 -2.07
    Full Income Statement

    Balance Sheet

    The company has 461.39M in cash and 13.27M in debt, giving a net cash position of 448.13M.

    Cash & Cash Equivalents

    n/a
    		 461.39M

    Total Debt

    n/a
    		 13.27M

    Net Cash

    n/a
    		 448.13M

    Retained Earnings

    n/a
    		 -187.59M

    Total Assets

    n/a
    		 550.67M

    Working Capital

    n/a
    		 511.73M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -64.32M and capital expenditures -2.24M, giving a free cash flow of -66.56M.

    Operating Cash Flow

    n/a
    		 -64.32M

    Capital Expenditures

    n/a
    		 -2.24M

    Free Cash Flow

    n/a
    		 -66.56M

    FCF Per Share

    n/a
    		 -1.69
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DICE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -6.64%

    FCF Yield

    n/a
    		 -5.41%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DICE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 42.89

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist